Literature DB >> 31228766

The role of Optical Coherence Tomography in Parkinsonism: A critical review.

Pooja Mailankody1, Abhishek Lenka1, Pramod Kumar Pal2.   

Abstract

Optical coherence tomography (OCT) has been evaluated as a tool to assess retinal changes in various neurodegenerative disorders. Parkinson's disease (PD), is a neurodegenerative disorder wherein dopaminergic deficiency results in some of the symptoms. As retina also has high concentration of dopamine, it would be of interest for both the clinician as well as the basic scientist to know if there is a correlation between the clinical features and the retinal changes. The objective of this review is to critically evaluate the literature and study the utility of OCT as a tool to evaluate retinal changes in PD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical parkinsonian disorders; OCT; Optical coherence tomography; Parkinson's disease

Year:  2019        PMID： 31228766     DOI： 10.1016/j.jns.2019.06.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  8 in total

1.  Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease.

Authors:  Jing Zou; Kangcheng Liu; Fangling Li; Yi Xu; Lu Shen; Huizhuo Xu
Journal:  Quant Imaging Med Surg       Date:  2020-10

Review 2.  Quantitative optical coherence tomography angiography: A review.

Authors:  Xincheng Yao; Minhaj N Alam; David Le; Devrim Toslak
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-20

3.  Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features.

Authors:  Bruce I Gaynes; Adnaan Zaffer; Raman Yousefzai; Mario Chazaro-Cortes; Kalea Colletta; Sandra L Kletzel; Mary Beth Jost; Youngsook Park; Jasvinder Chawla; Mark V Albert; Ting Xiao
Journal:  Neurol Sci       Date:  2021-05-04       Impact factor: 3.307

4.  Detection of Parkinson's Disease Through Automated Pupil Tracking of the Post-illumination Pupillary Response.

Authors:  Thasina Tabashum; Adnaan Zaffer; Raman Yousefzai; Kalea Colletta; Mary Beth Jost; Youngsook Park; Jasvinder Chawla; Bruce Gaynes; Mark V Albert; Ting Xiao
Journal:  Front Med (Lausanne)       Date:  2021-03-25

5.  The Retinal Posterior Pole in Early Parkinson's Disease: A Fundus Perimetry and SD-OCT Study.

Authors:  Massimo Cesareo; Ernesto Di Marco; Clarissa Giannini; Matteo Di Marino; Francesco Aiello; Antonio Pisani; Mariangela Pierantozzi; Nicola Biagio Mercuri; Carlo Nucci; Raffaele Mancino
Journal:  Clin Ophthalmol       Date:  2021-10-04

Review 6.  Enhanced medical diagnosis for dOCTors: a perspective of optical coherence tomography.

Authors:  Rainer Leitgeb; Fabian Placzek; Elisabet Rank; Lisa Krainz; Richard Haindl; Qian Li; Mengyang Liu; Marco Andreana; Angelika Unterhuber; Tilman Schmoll; Wolfgang Drexler
Journal:  J Biomed Opt       Date:  2021-10       Impact factor: 3.758

Review 7.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

Review 8.  Management of Visual Dysfunction in Patients with Parkinson's Disease.

Authors:  Joseph Savitt; Rachid Aouchiche
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.